You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for Patent: 5,061,703


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,061,703
Title: Adamantane derivatives in the prevention and treatment of cerebral ischemia
Abstract:A method for the prevention and treatment of cerebral ischemia using an adamantane derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 are identical or different, representing hydrogen or a straight or branched alkyl group of 1 to 6 C atoms or, in conjunction with N, a heterocyclic group with 5 or 6 ring C atoms; wherein R.sub.3 and R.sub.4 are identical or different, being selected from hydrogen, a straight or branched alkyl group of 1 to 6 C atoms, a cycloalkyl group with 5 or 6 C atoms, and phenyl; wherein R.sub.5 is hydrogen or a straight or branched C.sub.1 -C.sub.6 alkyl group, or a pharmaceutically-acceptable salt thereof, is disclosed.
Inventor(s): Bormann; Joachim (Frankfurt, DE), Gold; Markus R. (Nauheim, DE), Schatton; Wolfgang (Eschborn, DE)
Assignee: Merz + Co. GmbH & Co. (Frankfurt am Main, DE)
Application Number:07/508,109
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,061,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,061,703

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
89106657Apr 14, 1989

International Family Members for US Patent 5,061,703

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0392059 ⤷  Sign Up 90988 Luxembourg ⤷  Sign Up
European Patent Office 0392059 ⤷  Sign Up SPC/GB02/046 United Kingdom ⤷  Sign Up
European Patent Office 0392059 ⤷  Sign Up 2002C/035 Belgium ⤷  Sign Up
European Patent Office 0392059 ⤷  Sign Up 0290025-6 Sweden ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.